ILMN vs PSTV · rev $2.25B vs P/E 0.2, rev $5.8M
Illumina Inc (ILMN) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
ILMN currently screens at market cap $15.84B. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the ILMN and PSTV stock pages for the full models.
Not investment advice.